Effect of Sitagliptin on Postprandial Lipoprotein Metabolism

NCT00939939 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Recruitment failure

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: sitagliptin
DRUG: glimepiride

Sponsor

Ludwig-Maximilians - University of Munich